Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery

Molecular Therapy

Volumn 12, Issue 4, 2005, Pages 744-753

  Chadeuf, Gilliane ^a   Ciron, Carine ^a,b   Moullier, Philippe ^a,b   Salvetti, Anna ^a  

^a INSERM   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Adeno associated virus; DNA packaging; Gene transfer

Indexed keywords

BETA GLUCURONIDASE; CHEMOKINE RECEPTOR CCR5; CHORIONIC GONADOTROPIN; ERYTHROPOIETIN; LEVO IDURONIDASE; PARVOVIRUS VECTOR;

ANIMAL TISSUE; ARTICLE; BACTERIUM TRANSFORMATION; CONTROLLED STUDY; DNA PACKAGING; GENE SEQUENCE; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMID; PROKARYOTIC CELL; QUANTITATIVE ANALYSIS; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; BASE SEQUENCE; CAPSID; CELL LINE; DEPENDOVIRUS; DNA PACKAGING; DNA, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PLASMIDS; VIRUS INTEGRATION;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; BACTERIA (MICROORGANISMS); MIRIDAE; PROKARYOTA;

EID: 25144482280     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.06.003     Document Type: Article

References (37)

1. K.I. Berns and C. Giraud Biology of adeno-associated virus Curr. Top. Microbiol. Immunol. 218 1996 1-23
2. B.J. Carter E. Mendelson and J.P. Trempe AAV DNA replication, integration and genetics (P. Tjissen, Ed.) Handbook of Parvoviruses Vol. I 1990 CRC Press Boca Raton, FL 169-225
3. R.J. Samulski L.S. Chang and T. Shenk Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression J. Virol. 63 1989 3822-3828
4. R. Snyder S. Xiao and R.J. Samulski Production of recombinant adeno-associated viral vectors (N. Dracopoli, Ed.) Current Protocols in Human Genetics Vol. 1 1996 Wiley New York 12.1.1-12.1.23
5. D. Grimm A. Kern K. Rittner and J. Kleinschmidt Novel tools for production and purification of recombinant adeno-associated virus vectors Hum. Gene Ther. 9 1998 2745-2760
6. X. Xiao J. Li and R.J. Samulski Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J. Virol. 72 1998 2224-2232
7. G. Chadeuf et al. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome J. Gene Med. 2 2000 260-268
8. K.R. Clark F. Voulgaropoulou D.M. Fraley and P.R. Johnson Cell lines for the production of recombinant adeno-associated virus Hum. Gene Ther. 6 1995 1329-1341
9. C. Qiao B. Wang X. Zhu J. Li and X. Xiao A novel gene expression control system and its use in stable, high titer 293 cell-based adeno-associated virus packaging cell lines J. Virol. 76 2002 13015-13027
10. E. Toublanc et al. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines J. Gene Med. 6 2004 555-564
11. J.E. Conway et al. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I expressing AAV-2 rep and cap Gene Ther. 6 1999 986-993
12. J.M. Allen D.J. Debelak T.C. Reynolds and A.D. Miller Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by non homologous recombination during AAV vector production J. Virol. 71 1997 6816-6822
13. A. Salvetti et al. Factors influencing recombinant adeno-associated virus production Hum. Gene Ther. 9 1998 695-706
14. X.S. Wang et al. Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination J. Virol. 72 1998 5472-5480
15. P. Nony G. Chadeuf J. Tessier P. Moullier and A. Salvetti Evidence for packaging rep-cap sequences into AAV-2 capsids in the absence of the inverted terminal repeat: A model for the generation of rep+ AAV particles J. Virol. 77 2003 776-781
16. P. Nony et al. Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences J. Virol. 75 2001 9991-9994
17. D. Miller E. Rutledge and D. Russell Chromosomal effects of adeno-associated virus vector integration Nat. Genet. 30 2002 147-148
18. J. Gottlieb and N. Muzyczka In vitro excision of adeno-associated virus DNA from recombinant plasmids: Isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences Mol. Cell. Biol. 6 1988 2513-2522
19. R.J. Samulski K.I. Berns M. Tam and N. Muzyczka Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells Proc. Natl. Acad. Sci. USA 79 1982 2077-2081
20. R.J. Samulski L.S. Chang and T. Shenk A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication J. Virol. 61 1987 3096-3101
21. P. Ward and K.I. Berns In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome J. Mol. Biol. 218 1991 791-804
22. P. Ward F.B. Dean M.E. O'Donnell and K.I. Berns Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication J. Virol. 72 1998 420-427
23. P. Ward E. Urcelay R. Kotin B. Safer and K.I. Berns Adeno-associated virus DNA replication in vitro: Activation by a maltose binding protein/ Rep 68 fusion protein J. Virol. 68 1994 6029-6037
24. L.C. Mathews J.T. Gray M.R. Gallagher and R.O. Snyder Recombinant adeno-associated viral vector production using stable packaging and producer cell lines Methods Enzymol. 346 2002 393-413
25. J. Tessier and Characterization of adenovirus-induced inverted terminal repeat-independent amplification of integrated adeno-associated virus rep-cap sequences J. Virol. 75 2001 375-383
26. E. Feudner M. de Alwis A.J. Thrasher R.R. Ali and S. Fauser Optimization of recombinant adeno-associated virus production using a herpes simplex virus amplicon system J. Virol. Methods 96 2001 97-105
27. A.-L. Shiau P.-S. Liu and C.-L. Wu Novel strategy for generation and titration of recombinant adeno-associated virus vectors J. Virol. 79 2005 193-201
28. M. Urabe C. Ding and R.M. Kotin Insect cells as a factory to produce adeno-associated virus type 2 vectors Hum. Gene Ther. 13 2002 1935-1943
29. D.M. McCarty et al. Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein J. Virol. 68 1994 4988-4997
30. P. Chenuaud et al. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle Mol. Ther. 9 2004 410-418
31. J.A. Chiorini F. Kim L. Yang and R.M. Kotin Cloning and characterization of adeno-associated virus type 5 J. Virol. 73 1999 1309-1319
32. D. Duan et al. Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue J. Virol. 72 1998 8568-8577
33. H. Nakai et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo J. Virol. 75 2001 6969-6976
34. B.C. Schnepp K.R. Clark D.L. Klemanski C.A. Pacak and P.R. Johnson Genetic fate of recombinant adeno-associated virus vector genomes in muscle J. Virol. 77 2003 3495-3504
35. D. Grimm and M.A. Kay From virus evolution to vector revolution: Use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy Curr. Gene Ther. 3 2003 281-304
36. C.A. Laughlin J.D. Tratschin H. Coon and B.J. Carter Cloning of infectious adeno-associated virus genomes in bacterial plasmids Gene 23 1983 65-73
37. F.L. Graham and L. Prevec Manipulation of adenovirus vectors (E.J. Murray, Ed.) Gene Transfer and Protocol Vol. 7 1991 Humana Press Clifton, NJ 109-128